Chapter 1 - Introduction

[1]        Australian Medical Association, Submission 40, p. 2.

[2]        Medibank Private, Submission 14, p. 3.

[3]        Mr Matthew Koce, Chief Executive Officer, hirmaa, Committee Hansard, 16 March 2017, p. 18.

[4]        See, for example: Private Healthcare Australia, Submission 7; Medibank, Submission 14; BIB, Submission 16; HBF, Submission 27; HCF, Submission 28; Bupa, Submission 31; The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums', Media release, 19 October 2016.

[5]        The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums', Media release, 19 October 2016.

[6]        See, for example: Medical Technology Association of Australia, Submission 2; CONMED Linvatec Australia, Submission 5; Private Healthcare Australia, Submission 7; HBF, Submission 27; Joint submission from four Australian medical device manufacturers and distributors, Submission 39.

[7]        Journals of the Senate, No. 16, 21 November 2016, pp. 497-497.

[8]        Journals of the Senate, No. 34, 23 March 2017, p. 1150.

[9]        Journals of the Senate, No. 40, 10 May 2017, p. 1325.

[10]      See: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/ProsthesesListFramework.

[11]      Journals of the Senate, No. 16, 21 November 2016, pp. 497-497; See also: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/ProsthesesListFramework.

[12]      Department of Health, Submission 38, p. 8.

[13]      Department of Health, Submission 38, p. 2.

[14]      Private Health Insurance Act 2007, https://www.legislation.gov.au/Details/C2016C00911  (accessed 3 May 2017).

[15]      Private Health Insurance (Prostheses) Rules 2017 (No. 1), https://www.legislation.gov.au/Details/F2017C00240 (accessed 3 May 2017).

[16]      Department of Health, Submission 38, pp. 2, 4.

[17]      Department of Health, Submission 38, p. 2.

[18]      Department of Health, Submission 38, p. 4.

[19]      Department of Health, Submission 38, pp. 4-5.

[20]      Department of Health, Submission 38, pp. 4, 10.

[21]      Department of Health, Submission 38, p. 5.

[22]      Department of Health, Submission 38, p. 7.

[23]      Department of Health, Submission 38, pp. 5-6.

[24]      Department of Health, Submission 38, p. 6.

[25]      Department of Health, Submission 38, p. 6.

[26]      Department of Health, answers to written questions on notice (received 26 April 2017).

[27]      Department of Health, Submission 38, p. 6.

[28]      Department of Health, answers to written questions on notice (received 26 April 2017).

[29]      Department of Health, Submission 38, p. 2; Private Health Insurance (Prostheses Application and Listing Fee) Rules 2008 (No. 1).

[30]      Department of Health, Submission 38, p. 2.

[31]      Department of Health, Submission 38, p. 2.

[32]      Medibank, Submission 14, p. 3.

[33]      Department of Health, Submission 38, p. 2.

[34]      Medibank, Submission 14, p. 3.

[35]      Medibank, Submission 14, p. 3.

[36]      Department of Health, Submission 38, p. 1.

Chapter 2 - The Prostheses List in Practice

[1]        Department of Health, Submission 38, p. 8.

[2]        Department of Health, Submission 38, p. 8.

[3]        Department of Health, Submission 38, p. 9.

[4]        Department of Health, Submission 38, p. 9.

[5]        Department of Health, Submission 38, p. 9.

[6]        Department of Health, Submission 38, p. 9.

[7]        Department of Health, Submission 38, p. 9.

[8]        Department of Health, Submission 38, pp. 9-10.

[9]        Department of Health, Submission 38, p. 10.

[10]      Department of Health, Submission 38, p. 10.

[11]      Department of Health, Submission 38, p. 10.

[12]      Department of Health, Submission 38, p. 10.

[13]      hirmaa, Submission 12, pp. 2-3, 5.

[14]      See, for example: Applied Medical, Submission 41; Private Healthcare Australia, Submission 7.

[15]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 62.

[16]      Department of Health, Submission 38, Attachment A.

[17]      The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums', Media release, 19 October 2016.

[18]      The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums', Media release, 19 October 2016.

[19]      Private Healthcare Australia, Submission 7, [p. 8].

[20]      Mr Gavin Fox-Smith, Managing Director, Johnson & Johnson Medical Devices ANZ, Committee Hansard, 15 March 2017, p. 10.

[21]      See, for example: Private Healthcare Australia, Submission 7; [pp. 6-7]; Bupa, Submission 31, pp. 6-7; Applied Medical, Submission 41, Attachment 1, pp. 4-5.

[22]      Bupa, Submission 31, p. 6.

[23]      Private Healthcare Australia, Submission 7, p. [3].

[24]      HBF, Submission 27, [p. 3]; See also, Australian Medical Association, Submission 40, p. 1.

[25]      HBF, Submission 27, [p. 3].

[26]      MTAA, Submission 2, p. 12.

[27]      MTAA, Submission 2, p. 3.

[28]      Mr Gavin Fox-Smith, Managing Director, Johnson & Johnson Medical Devices ANZ, Committee Hansard, 15 March 2017, p. 10.

[29]      HBF, Submission 27, [p. 4].

[30]      Medibank Private, Submission 14, p. 3.

[31]      The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums', Media release, 19 October 2016.

[32]      Mr Craig Drummond, Chief Executive Officer, Medibank Private, Committee Hansard, 31 March 2017, p. 2.

[33]      Medibank Private, Submission 14, p. 4; Bupa, Submission 31, p. 3.

[34]      Private Healthcare Australia, Submission 7; [pp. 6-7]; Bupa, Submission 31, pp. 6-7; Applied Medical, Submission 41, Attachment 3, p. 3; Department of Health, Submission 38, Attachment E, Industry Working Group on Private Health Insurance Prostheses Reform - Final report, p. 7.

[35]      Productivity Commission, Performance of Public and Private Hospital Systems Research Report, 10 December 2009, http://www.pc.gov.au/inquiries/completed/hospitals/report (accessed 1 May 2017).

[36]      Bupa, Submission 31, pp. 6-7 (footnotes omitted).

[37]      HBF, Submission 27, [p. 2].

[38]      Department of Health and Ageing, Review of Health Technology Assessment in Australia, December 2009, p. 94 https://www.health.gov.au/internet/main/publishing.nsf/Content/AF68234CE9EB8A78CA257BF00018CBEB/$File/hta-review-report.pdf (accessed 3 May 2017).

[39]      Private Healthcare Australia, Costing an arm and a leg, October 2015, p. 6, http://www.privatehealthcareaustralia.org.au/wp-content/uploads/PHA-Report-Costing-an-arm-and-a-leg-Oct-2015.pdf (accessed 1 May 2017).

[40]      Bupa, Submission 31, p. 8.

[41]      See, for example: Private Healthcare Australia, Submission 7; Medibank Private, Submission 14; BIB, Submission 16; HBF, Submission 27; HCF, Submission 28; Bupa, Submission 31.

[42]      Mr Ian Burgess, Chief Executive Officer, Medical Technology Association of Australia, Committee Hansard, 15 March 2017, p. 1.

[43]      Medical Technology Association Australia (MTAA), Submission 2, p. 7.

[44]      Mr Michael Roff, Chief Executive Officer, Australian Private Hospital Association, Committee Hansard, 16 March 2017, p. 35.

[45]      Dr Peter Lewis, Deputy Director, Australian Orthopaedic Association, Committee Hansard, 16 March 2017, p. 53.

[46]      Australian Orthopaedic Association Code of Conduct for Members 2010, p. 8, https://www.aoa.org.au/docs/default-source/ecm-files/codeofconduct2010_240910_pdf.pdf?sfvrsn=2 (accessed 1 May 2017).

[47]      Dr Peter Lewis, Deputy Director, Australian Orthopaedic Association, Committee Hansard, 16 March 2017, p. 52.

[48]      Biotronik Australia Pty Ltd, Submission 22.1, [p. 2]; Australian Medical Association, Submission 40, p. 3; Mr Maurice Ben-Mayor, Managing Director, Stryker Australia, Committee Hansard, 15 March 2017, pp. 16-17; Dr Simon Woods, Executive Director, Malvern, Cabrini, Committee Hansard, 16 March 2017, p. 30; Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 70; Mr Michael Craig Sammells, Chief Financial Officer, Healthscope Ltd, Committee Hansard, 31 March 2017, p. 7.

[49]      Dr Simon Woods, Executive Director, Malvern, Cabrini, Committee Hansard, 16 March 2017, p. 30.

[50]      Name withheld, Submission 34, [p. 3].

[51]      Mr Michael Roff, Chief Executive Officer, Australian Private Hospital Association, Committee Hansard, 16 March 2017, pp. 34-35.

[52]      Mr Christopher Rex, Chief Executive Officer, Ramsay Health Care, Committee Hansard, 31 March 2017, pp. 13-14.

[53]      Private Healthcare Australia, Submission 7, [p. 9].

[54]      Applied Medical, Submission 41, Attachment A, pp. 6-7; Applied Medical, Submission 41.1, p. 18; Dr Rachel David, Chief Executive Officer, Private Healthcare Australia, Committee Hansard, 16 March 2017, p. 25.

[55]      Dr Andrew Wilson, Group Executive, Healthcare Strategy, Medibank Private, Committee Hansard, 31 March 2017, p. 4.

[56]      Medibank Private, Submission 14, p. 2.

[57]      Mr Craig Drummond, Chief Executive Officer, Medibank Private, answers to questions on notice, 31 March 2017 (received 11 April 2017).

[58]      Ms Josephine Root, Policy Manager, Consumers Health Forum of Australia, Committee Hansard, 16 March 2017, p. 8.

[59]      Private Healthcare Australia, Submission 7, [p. 5].

[60]      Ms Josephine Root, Policy Manager, Consumers Health Forum of Australia, Committee Hansard, 16 March 2017, p. 8.

[61]      Department of Health, Prostheses List Advisory Committee, Committee Members, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-PLAC (accessed 4 May 2017).

[62]      Mr Nicolas Taylor, Regulatory Consultant, Applied Medical, Committee Hansard, 16 March 2017, p. 6.

[63]      Department of Health, Submission 38, p. 3.

[64]      Department of Veterans' Affairs, Submission 20, p. 2.

[65]      Department of Veterans' Affairs, Submission 20, p. 3.

[66]      Department of Veterans' Affairs, Submission 20, p. 3.

[67]      Australian Medical Association, Submission 40, p. 3.

[68]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, pp. 69-70.

[69]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 69.

[70]      Mr Glenn Cross, Chief Executive Officer, AusBiotech Ltd, Committee Hansard, 16 March 2017, p. 41.

[71]      hirmaa, Submission 12, p. 2.

[72]      Australian Medical Association, Submission 40, p. 3.

[73]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 70.

[74]      Mr Glenn Cross, Chief Executive Officer, AusBiotech Ltd, Committee Hansard, 16 March 2017, p. 41.

[75]      MTAA, Submission 2, p. 5.

[76]      For information in relation to the VAIOS case, see: Orthotech Pty Ltd v Minister for Health [2013] FCA 230, http://www.judgments.fedcourt.gov.au/judgments/Judgments/fca/single/2013/2013fca0230  (accessed 11 May 2017).

[77]      Bupa, Submission 31, p. 10.

[78]      Department of Health, Submission 38, Attachment F.

[79]      Department of Health, answers to written questions on notice (received 26 April 2017).

[80]      Private Healthcare Australia, Submission 7, p. 10; Bupa, Submission 31, p. 3.

[81]      Mr Glenn Cross, Chief Executive Officer, AusBiotech Ltd, Committee Hansard, 16 March 2017, p. 41.

[82]      Medtronic, Submission 36, p. 15.

[83]      Private Healthcare Australia, Costing an arm and a leg, October 2015, p. 6, http://www.privatehealthcareaustralia.org.au/wp-content/uploads/PHA-Report-Costing-an-arm-and-a-leg-Oct-2015.pdf (accessed 1 May 2017).

[84]      Mr Ian Burgess, Chief Executive Officer, Medical Technology Association of Australia, Committee Hansard, 15 March 2017, p. 2.

[85]      Mr Ian Burgess, Chief Executive Officer, Medical Technology Association of Australia, Committee Hansard, 15 March 2017, p. 2.

[86]      Mr Martin Bowles PSM, Secretary, and Mr Andrew Stuart, Deputy Secretary, Health Benefits Group, Department of Health, Committee Hansard, 19 October 2016, pp. 97-98; Mr Andrew Stuart, Deputy Secretary, Health Benefits Group, Department of Health, Committee Hansard, 16 March 2017, p. 69.

Chapter 3 - Prostheses List reforms

[1]        Senate Community Affairs References Committee, Inquiry into The Regulatory Standards for the Approval of Medical Devices, November 2011, https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/Completed_inquiries/2010-13/medicaldevices/report/index (accessed 28 April 2017), p. 91.

[2]        Department of Health, Submission 38, Attachment E.   

[3]        Emeritus Professor Lloyd Sansom AO was also previously part of a panel of three independent experts who undertook a broader review of health technology regulation in 2015, the Expert Review of Medicines and Medical Devices (MMDR). For further information on the MMDR go to Expert Review of Medicines and Medical Devices, http://www.health.gov.au/internet/main/publishing.nsf/Content/Expert-Review-of-Medicines-and-Medical-Devices-Regulation (accessed 11 April 2017).

[4]        Department of Health, Submission 38, Attachment E, p. 3.

[5]        Department of Health, Submission 38, Attachment E, p. 1.

[6]        Department of Health, Submission 38, p. 11.

[7]        Industry Working Group on Private Health Insurance Prostheses Reform Final Report, http://www.health.gov.au/internet/main/publishing.nsf/content/iwg-phi-pros-ref (accessed
20 April 2017), pp. 1-2.

[8]        Department of Health, Submission 38, p. 12.

[9]        The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums,' Media release, 19 October 2016 (accessed 10 April 2017).

[10]      The Hon Greg Hunt MP, Minister for Health, 'Prostheses reforms to deliver better value for private health insurance,' Media release, 4 May 2017 (accessed 4 May 2017).

[11]      The Hon Sussan Ley MP, former Minister for Health and Aged Care, 'Turnbull Government to ease pressure on private health insurance premiums,' Media release, 19 October 2016 (accessed 10 April 2017).

[12]      Ms Tracey Duffy, Assistant Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 64.

[13]      Available to view on the Federal Register of Legislation, https://www.legislation.gov.au/Details/F2017C00119 (accessed 18 April 2017).

[14]      Department of Health, Prostheses List Benefit Reductions, Private Health Insurance (Prostheses) Amendment Rules 2016 (No. 4) and Private Health Insurance (Prostheses) Amendment Rules 2017 (No.1), http://www.health.gov.au/internet/main/publishing.nsf/content/prostheses-list-benefit-reductions (accessed 12 April 2017).

[15]      Explanatory Statement, Private Health Insurance Act 2007, Private Health Insurance (Prostheses) Amendment Rules 2017 (No. 1), https://www.legislation.gov.au/Details/F2017L00089/Explanatory%20Statement/Text (accessed 21 April 2017).

[16]      Department of Health, Submission 38, Attachment E, pp. 17-18.

[17]      Department of Health, Submission 38, Attachment E, p. 8.

[18]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 69.

[19]      Mr Andrew Stuart, Deputy Secretary, Department of Health, answers to written questions on notice, 13 April 2017, (received 26 April 2017).

[20]      Department of Health, Submission 38, Attachment E, p. 8.

[21]      Department of Health, Submission 38, Attachment E, p. 8.

[22]      Joint submission from four Australian medical device manufacturers and distributors, Submission 39.1, [p. 5].

[23]      Biotronik Australia Pty Ltd, Submission 22, p.5.

[24]      Medical Technology Association of Australia, answers to questions on notice, 15 March 2017, received 29 March 2017, p. 1.

[25]      Medical Technology Association of Australia, answers to questions on notice, 15 March 2017, received 29 March 2017, p. 1.

[26]      Ms Andrea Kunca, Director of Access, Policy, Procurement and Innovation, Medical Technology Association of Australia, Committee Hansard, 15 March 2017, p. 5.

[27]      Mr Craig Drummond, Chief Executive Officer, Medibank Private, Committee Hansard,
31 March 2017, p. 2.

[28]      The Hon Greg Hunt MP, Minister for Health, correspondence to Mr Shane Solomon, Chair, Independent Hospital Pricing Authority, provided by Mr Andrew Stuart, Deputy Secretary, Department of Health, answers to questions on notice, 16 March 2017, received 29 March 2017.

[29]      The Hon Greg Hunt MP, Minister for Health, correspondence to Mr Shane Solomon, Chair, Independent Hospital Pricing Authority, provided by Mr Andrew Stuart, Deputy Secretary, Department of Health, answers to questions on notice, 16 March 2017, received 29 March 2017.

[30]      The Hon Greg Hunt MP, Minister for Health, correspondence to Mr Shane Solomon, Chair, Independent Hospital Pricing Authority, provided by Mr Andrew Stuart, Deputy Secretary, Department of Health, answers to questions on notice, 16 March 2017, received 29 March 2017.

[31]      Prostheses List Advisory Committee Operational Guidelines, December 2016, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-plac (accessed 11 April 2017).

[32]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 71.

[33]      Department of Health, Submission 38, Attachment B, p. 1.

[34]      Mr Andrew Stuart, Deputy Secretary, Department of Health, answers to written questions on notice, 13 April 2017 (received 26 April 2017).

[35]      Department of Health, Cost Recovery Implementation Statement: Administration of the Prostheses List 1 July to 30 June 2017, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-prostheseslist.htm (accessed 19 April 2017), p. 3.

[36]      Budget 2016–17, Part 2: Expense Measures, http://www.budget.gov.au/2016-17/content/bp2/html/bp2_expense-15.htm (accessed 28 April 2017).

[37]      Applied Medical, Submission 41; Private Healthcare Australia, Submission 7; Australian Medical Association, Submission 40.

[38]      Biotronik Australia Pty Ltd, Submission 22, p. 7.

[39]      Mr Nicolas Taylor, Applied Medical, Committee Hansard, 16 March 2017, pp. 5-6.

[40]      Department of Health, Cost Recovery Implementation Statement: Administration of the Prostheses List, 1 July 2016 – 30 June 2017, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-prostheseslist.htm (accessed 20 April 2017), p. 3.

[41]      Department of Health, Cost Recovery Implementation Statement: Administration of the Prostheses List 1 July to 30 June 2017, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-prostheseslist.htm (accessed 19 April 2017), p. 3.

[42]      Department of Health, Cost Recovery Implementation Statement: Administration of the Prostheses List, 1 July 2016 – 30 June 2017, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-prostheseslist.htm (accessed 20 April 2017), p. 8.

[43]      Department of Health, Submission 38, p. 12.

[44]      Department of Health, Submission 38, Attachment F.

[45]      Department of Health, Prostheses List Advisory Committee, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-PLAC (accessed 20 April 2017).

[46]      The information in this table is derived from the five communiques published to date by the PLAC and a media release of 4 May 2017, the Hon Greg Hunt MP, Minister for Health, Prostheses reforms to deliver better value for private health insurance, http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2017-hunt043.htm . The communiques are available at Department of Health, Prostheses List Advisory Committee, http://www.health.gov.au/internet/main/publishing.nsf/Content/health-privatehealth-PLAC.

[47]      Prostheses List Advisory Committee Communique No.3, Department of Health, http://www.health.gov.au/internet/main/publishing.nsf/Content/EE9D7DA6EA42BDE0CA257BF00020623C/$File/PLAC%20communique%20No%203.pdf (accessed 21 April 2017), p.1.

[48]      Professor Terry Campbell, Chair, Prostheses List Advisory Committee, Committee Hansard,
16 March 2017, p. 57.

[49]      The Hon. Robert Doyle, Review of the Prostheses Listing Arrangements, 2007; Review of Health Technology Assessment in Australia, 2009; Senate Community Affairs Committee, Availability of new, innovative and specialist cancer drugs in Australia, 2015; Senate Community Affairs Committee, The regulatory standards for the approval of medical devices in Australia, 2011.

[50]      See for example, Royal Australasian College of Surgeons, Submission 17; Stryker, Submission 29; Australian Medical Association, Submission 40.

[51]      Department of Health, Submission 38, Attachment E, p. 4.

[52]      'Review of Medicines and Medical Devices: Terms of Reference', Expert Review of Medicines and Medical Devices Regulation, http://www.health.gov.au/internet/main/publishing.nsf/content/expert-review-of-medicines-and-medical-devices-regulation (accessed 24 April 2017).

[53]      Emeritus Professor Lloyd Sansom AO, Mr Will Delaat AM, Professor John Horvath AO, Expert Panel Review of Medicines and Medical Devices Regulation: Report to the Minister for Health on the Regulatory Framework for Medicines and Medical Devices, 31 March 2015, http://www.health.gov.au/internet/main/publishing.nsf/Content/Expert-Review-of-Medicines-and-Medical-Devices-Regulation#report1 (accessed 12 April 2017), pp. 171-172.

[54]      Department of Health, Australian Government Response to the Review of Medicines and Medical Devices Regulation May 2016, http://www.health.gov.au/internet/main/publishing.nsf/Content/MMD-govresp (accessed
12 April 2017), p. 27.

[55]      Department of Health, Submission 38, Attachment F.

[56]      Prostheses List Advisory Committee, Communique No. 2 and Communique 3, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-plac.

[57]      Department of Health, Submission 38, p. 3.

[58]      Prostheses List Advisory Committee, Communique 3, December 2016, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-plac.

Chapter 4

[1]        Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 69.

[2]        Professor Terry Campbell, Chair, Prostheses List Advisory Committee, Committee Hansard, 16 March 2017, p. 56.

[3]        Private Healthcare Australia, Submission 7, [p.7].

[4]        Private Healthcare Australia, Pre-Budget Submission 2017-18, 19 January 2017, https://www.treasury.gov.au/~/media/Treasury/Consultations%20and%20Reviews/Consultations/2016/2017%20PreBudget%20submissions/Submissions/PDF/Private%20Healthcare%20Australia.ashx (accessed 19 April 2017), p. 17.

[5]        Mr Christopher Rex, Managing Director, Ramsay Health Care Limited, answers to questions on notice, 31 March 2017 (received 13 April 2017).

[6]        Catholic Health Australia, Submission 25, p. 2.

[7]        Department of Health, Submission 38, Attachment F, [p. 2].

[8]        Department of Health, Submission 38, Attachment F, [p. 2].

[9]        See for example: Medical Technology Association of Australia, Submission 2, p. 21; Cochlear Limited, Submission 8, p. 14; Catholic Healthcare Australia, Submission 25, p. 3; Stryker Australia Pty Ltd, Submission 29, p. 9; Australian Medical Association, Submission 40, p. 4; Healthscope, Submission 42, p. 6.

[10]      Department of Health, Submission 38, Attachment E, p. 4.

[11]      Cochlear Limited, Submission 8, p. 4.

[12]      Dr Janet Wale, Submission 11, [p. 2].

[13]      Dr Janet Wale, Submission 11, [p. 3].

[14]      See for example: MTAA, Submission 2; Cochlear Limited, Submission 8; Catholic Health Australia, Submission 25.

[15]      Applied Medical, Submission 41, Attachment B, p. 11.

[16]      Applied Medical, Supplementary submission 41, p. 4.

[17]      Biotronik Australia, Submission 22, p. 6.

[18]      Joint submission from four Australian medical device manufacturers and distributors, Submission 39, Attachment 1, [p. 2].

[19]      Cochlear Limited, Submission 8, p. 10.

[20]      Name withheld, Submission 43, [p. 4].

[21]      Department of Health, Submission 38, Attachment E, p. 9.

[22]      Mr Chris Rex, Chief Executive Officer, Ramsay Health Care, Committee Hansard, 31 March 2017, p. 12.

[23]      Department of Health, answers to written questions on notice, 16 April 2017 (received 26 April 2017).

[24]      Biotronik Australia Pty Ltd, Submission 22.1, p. 6.

[25]      Biotronik Australia Pty Ltd, Submission 22.1, p. 6.

[26]      Applied Medical, Supplementary submission 41, p. 7.

[27]      Cochlear Limited, Submission 8, p. 12.

[28]      Cochlear Limited, Submission 8, pp. 11-13.

[29]      AusBiotech Ltd, Submission 15, p. 4.

[30]      Mr Michael Sammells, Chief Financial Officer, Healthscope Ltd, Committee Hansard, 31 March 2017, p. 7.

[31]      Mr Michael Sammells, Chief Financial Officer, Healthscope Ltd, Committee Hansard, 31 March 2017, p. 8.

[32]      See for example: Australian Diabetes Society and Endocrine Society of Australia,
Submission 9; Dr Janet Wale, Submission 11; AusBiotech, Submission 15; Medtronic, Submission 36.

[33]      Department of Health, Submission 38, Attachment E, p. 7.

[34]      Department of Health, Submission 38, pp. 12-13.

[35]      Health Economics Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Prostheses Benefit Setting Framework: Comparative analysis of benefit setting models, Department of Health, March 2017, http://www.health.gov.au/internet/main/publishing.nsf/Content/EE9D7DA6EA42BDE0CA257BF00020623C/$File/PROSTHESES%20BENEFIT%20SETTING%20FRAMEWORK_SENT_DOH_1%20V2.PDF (accessed 4 May 2017).

[36]      Professor Terry Campbell, Chair, Prostheses List Advisory Committee, Committee Hansard, 16 March 2017, p. 57.

[37]      Department of Health, answers to written questions on notice, 16 April 2017 (received 26 April 2017).

[38]      Department of Health, Submission 38, Attachment F, [p.1].

[39]      MTAA, Submission 2, p. 13.

[40]      Cochlear Limited, Submission 8, p.15.

[41]      Healthscope, Submission 42, p. 6.

[42]      Private Healthcare Australia, Submission 7, [p. 12].

[43]      See, for example: Styker Australia, Submission 29; Joint submission from four Australian medical device manufacturers and distributors, Submission 39.

[44]      Department of Health, Submission 38, p. 10.

[45]      Mr Matthew Koce, Chief Executive Officer, hirmaa, Committee Hansard, 16 March 2017, pp. 19-20.

[46]      Dr Simon Woods, Executive Director, Malvern, Cabrini, Committee Hansard, 16 March 2017, p. 31.

[47]      Ausbiotech, Submission 15, p. 8.

[48]      Applied Medical, Supplementary submission 41, p. 17.

[49]      See for example: Private Healthcare Australia, Submission 7; Applied Medical, Supplementary submission 41.

[50]      Private Healthcare Australia, Submission 7, [p. 8].

[51]      Medical Technology Association of Australia, Submission 2.1, p. 5.

[52]      Dr Simon Woods, Executive Director, Malvern, Cabrini, Committee Hansard, 16 March 2017, p. 32.

[53]      Stryker Australia, Pty Ltd, Submission 29, p. 9.

[54]      Dr Peter Lewis, Deputy Director, Australian Orthopaedic Association National Joint Replacement Registry, Australian Orthopaedic Association, Committee Hansard, 16 March 2017, p. 46.

[55]      Department of Health, Submission 38, Attachment E, p. 10.

[56]      Department of Health, Submission 38, Attachment E, p. 10.

[57]      Ms Tracy Duffy, Assistant Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 66.

[58]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 66.

[59]      Ms Tracy Duffy, Assistant Secretary, Department of Health, Committee Hansard, 16 March 2017, p. 66.

[60]      Mr Andrew Stuart, Deputy Secretary, Department of Health, Committee Hansard, 16 March 2017, pp. 66-67.

[61]      IHPA, Submission 37, [pp. 1-2].

[62]      IHPA, Submission 37, [p. 1].

[63]      IHPA, Submission 37, [p. 1].

[64]      IHPA, Submission 37, [p. 1].

[65]      IHPA, answers to questions on notice, 15 March 2017 (received 3 April 2017).

[66]      IHPA, answers to questions on notice, 15 March 2017 (received 3 April 2017).

[67]      Australian Refined Diagnosis Related Groups (AR-DRGs) is an Australian admitted patient classification system which provides a clinically meaningful way of relating the number and type of patients treated in a hospital to the resources required by the hospital. Each AR-DRG represents a class of patients with similar clinical conditions requiring similar hospital services. See: http://www.aihw.gov.au/hospitals-data/ar-drg-data-cubes/ (accessed 11 May 2017).

[68]      Department of Health, Submission 38, p. 13.

[69]      Cochlear Limited, Submission 8, p. 4.

[70]      Cochlear Limited, Submission 8, p. 4.

APPENDIX 3 - Prostheses List Advisory Committee

[1]        Prostheses List Advisory Committee, Department of Health, http://www.health.gov.au/internet/main/publishing.nsf/content/health-privatehealth-plac (accessed 8 May 2017).